• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by AdaptHealth Corp. (Amendment)

    5/16/23 8:02:28 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email
    SC 13D/A 1 d466661dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    AdaptHealth Corp.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    00653Q102

    (CUSIP Number)

    Theodore B. Lundberg

    Peloton Equity, LLC

    66 Field Point Road, 2nd Floor

    Greenwich, CT 06831

    (203) 532-8011

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    May 15, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Peloton Equity AeroCare SPV I, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      4,460,555

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      4,460,555

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      4,460,555

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      3.3% (1)

    14.  

      Type of Reporting Person (See Instructions)

     

      PN

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Peloton Equity AeroCare SPV II, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      422,898

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      422,898

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      422,898

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      0.3% (2)

    14.  

      Type of Reporting Person (See Instructions)

     

      PN

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Peloton Equity I, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      WC

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      1,428,109

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      1,428,109

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,428,109

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      1.1% (1)

    14.  

      Type of Reporting Person (See Instructions)

     

      PN

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Peloton Equity GP, LLC

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      6,987,394

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      6,987,394

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      6,987,394

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      5.2% (1)

    14.  

      Type of Reporting Person (See Instructions)

     

      OO

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Theodore B. Lundberg

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      United States of America

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      7,001,224

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      7,001,224

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      7,001,224

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      5.2% (1)

    14.  

      Type of Reporting Person (See Instructions)

     

      IN

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    CUSIP No. 00653Q102

     

      1.    

      Names of Reporting Persons.

     

      Carlos A. Ferrer

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds (See Instructions)

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      United States of America

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

         7.     

      Sole Voting Power

     

      6,987,394

         8.   

      Shared Voting Power

     

      0

         9.   

      Sole Dispositive Power

     

      6,987,394

       10.   

      Shared Dispositive Power

     

      0

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      6,987,394

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      5.2% (1)

    14.  

      Type of Reporting Person (See Instructions)

     

      IN

     

    (1)

    The percent of class was calculated based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.


    Explanatory Statement

    This Amendment No. 1 amends and supplements the Schedule 13D originally filed by the Reporting Persons on March 15, 2021 (the “Schedule 13D”) with respect to the shares of Common Stock, par value $0.0001 per share (the “Common Stock”) of AdaptHealth Corp. (the “Issuer”). Capitalized terms used herein and not otherwise defined shall have the same meanings ascribed to them in the Schedule 13D.

    Item 2. Identity and Background

    Item 2 of the Schedule 13D is hereby supplemented as follows:

    The principal business address of each Reporting Person is 66 Field Point Road, 2nd Floor, Greenwich, CT 06831.

    Item 5. Interest in Securities of the Issuer

    Item 5 of the Schedule 13D is hereby amended and restated as follows:

    Item 5(a)-(b). The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on 134,172,442 shares of Common Stock outstanding as of May 5, 2023, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2023.

    Peloton Equity AeroCare SPV I, L.P. (“Peloton AeroCare I”) is the direct beneficial owner of 4,460,555 shares of Common Stock, which in the aggregate represents approximately 3.3% of the outstanding Common Stock.

    Peloton Equity AeroCare SPV II, L.P. (“Peloton AeroCare II”) is the direct beneficial owner of 422,898 shares of Common Stock, which in the aggregate represents approximately 0.3% of the outstanding Common Stock.

    Peloton Equity I, L.P. (“Peloton Equity I” and together with Peloton AeroCare I and Peloton AeroCare II, the “Peloton Funds”) is the direct beneficial owner of 1,428,109 shares of Common Stock, which in the aggregate represents approximately 1.1% of the outstanding Common Stock.

    Peloton Equity GP, LLC (“Peloton Equity GP”) is the direct beneficial owner of 675,832 shares of Common Stock, and as the general partner of the Peloton Funds, may be deemed to beneficially own 6,311,562 shares of Common Stock held by the Peloton Funds, which in the aggregate represents approximately 5.2% of the outstanding Common Stock.

    Mr. Lundberg is the direct beneficial owner of 13,830 shares of Common Stock. In addition, Mr. Lundberg and Mr. Ferrer, as the managing members of Peloton Equity GP, may be deemed to beneficially own the shares held directly by the Peloton Funds and Peloton Equity GP.

    The above percentages of beneficial ownership were determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended.

    Item 5(c). On May 15, 2023, each of Peloton AeroCare I, Peloton AeroCare II and Peloton Equity I distributed to their limited partners and sole general partner, Peloton Equity GP, pro rata and without consideration, 2,220,278 shares, 211,449 shares and 714,054 shares, respectively, of Common Stock. In connection with the distributions described herein, Peloton Equity GP received 675,832 shares of Common Stock.

    Item 5(d). Not applicable.

    Item 5(e). Not applicable.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: May 16, 2023

     

    PELOTON EQUITY AEROCARE SPV I, L.P.

     

    By: Peloton Equity GP, LLC

    General Partner

    By:  

    /s/ Theodore B. Lundberg

     

    Theodore B. Lundberg

    Managing Member

     

    PELOTON EQUITY AEROCARE SPV II, L.P.

     

    By: Peloton Equity GP, LLC

    General Partner

    By:  

    /s/ Theodore B. Lundberg

     

    Theodore B. Lundberg

    Managing Member

     

    PELOTON EQUITY I, L.P.

     

    By: Peloton Equity GP, LLC

    General Partner

    By:  

    /s/ Theodore B. Lundberg

     

    Theodore B. Lundberg

    Managing Member

     

    PELOTON EQUITY GP, LLC
    By:  

    /s/ Theodore B. Lundberg

     

    Theodore B. Lundberg

    Managing Member

     

    /s/ Theodore B. Lundberg

    THEODORE B. LUNDBERG

    /s/ Carlos A. Ferrer

    CARLOS A. FERRER
    Get the next $AHCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdaptHealth Corp. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO4Q25 Webcast registration: Clic

    2/3/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces Upgraded Moody's Ratings

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Moody's Ratings (Moody's) has recently upgraded the ratings of AdaptHealth, LLC, including the Corporate Family Rating to Ba2 from Ba3 and the senior unsecured notes rating from Ba3 to B1. "Moody's Ratings' upgrade follows S&P Global Ratings' upgrade of our issue-level rating on our senior unsecured debt in November 2025 and is yet another important recognition of the actions we are taking to strengthen our balance sheet, improve our risk profile, and in

    1/27/26 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. to Participate in Upcoming Investor Conference

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the BofA Securities Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 2, 2025, including a fireside chat at 8:10 a.m. ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations." About AdaptHealth Corp. AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, an

    11/26/25 8:30:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CLO and General Counsel Rew Richard W. Ii was granted 53,688 shares, increasing direct ownership by 111% to 102,097 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    2/3/26 8:24:34 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Chief Commercial Officer Schuster Iii Russell E. was granted 48,807 shares, increasing direct ownership by 49% to 147,813 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    2/3/26 8:23:25 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Chief Operating Officer Barnhart Toby Scott was granted 68,330 shares, increasing direct ownership by 45% to 220,654 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    2/3/26 8:22:19 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.

    SCHEDULE 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    2/5/26 1:16:32 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.

    SCHEDULE 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/13/25 4:26:52 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by AdaptHealth Corp.

    10-Q - AdaptHealth Corp. (0001725255) (Filer)

    11/4/25 4:55:21 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdaptHealth downgraded by Jefferies with a new price target

    Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

    1/8/24 9:03:40 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by BofA Securities with a new price target

    BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

    11/8/23 6:22:25 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

    5/10/23 6:33:54 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Financials

    Live finance-specific insights

    View All

    AdaptHealth Corp. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO4Q25 Webcast registration: Clic

    2/3/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces Third Quarter 2025 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2025. Third Quarter Business Highlights Signed another new capitated agreement to be the exclusive HME provider for a payor serving approximately 170,000 members, and added infrastructure to support our previously announced capitated partnership with a major national healthcare system. Advanced digital patient engagement and expanded self-service capabilities, growing registered myApp users to 271

    11/4/25 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces Third Quarter 2025 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2025 financial results before the opening of the financial markets on Tuesday, November 4, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4849 (Domestic) or (203) 518-9848 (International) When prompted, reference Conference ID: AHCO2Q25 Webcast registration: Click Here Followi

    10/13/25 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Leadership Updates

    Live Leadership Updates

    View All

    AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

    12/3/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Appoints Diana Nole to Board of Directors

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B

    10/17/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities

    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/14/24 9:03:31 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AdaptHealth Corp.

    SC 13G - AdaptHealth Corp. (0001725255) (Subject)

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/12/24 1:30:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care